Form 4 holding
President and CEO, Director
VOLITIONRX LTD
- Security class
- Common Stock
- Shares / value
- 3,115,547
- Estimated value
- $778,886
- Report date
- 26 Feb 2026
- Price
- $0.2500
- Ownership
- Direct
Cameron John Reynolds
Insider Reports History
- Reporting-owner location
- Henderson, NV
- Latest reporting-owner signature
-
/s/ Cameron John Reynolds
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Cameron John Reynolds
Form 4 holding
President and CEO, Director
VOLITIONRX LTD
- Security class
- Common Stock
- Shares / value
- 1,007,718
- Estimated value
- $251,929
- Report date
- 26 Feb 2026
- Price
- $0.2500
- Ownership
- By Concord International, Inc.
Form 4 holding
President and CEO, Director
VOLITIONRX LTD
- Security class
- Common Stock
- Shares / value
- 34,076
- Estimated value
- $8,519
- Report date
- 26 Feb 2026
- Price
- $0.2500
- Ownership
- By Spouse
Form 4 holding
President and CEO, Director
VOLITIONRX LTD
- Security class
- Warrant (Right to Buy)
- Shares / value
- 110,000
- Estimated value
- Report date
- 14 Oct 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Cameron John Reynolds
4
VNRX
VOLITIONRX LTD
- Report period
- 26 Feb 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 27 Feb 2026, 16:32
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 22 Jan 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 23 Jan 2026, 16:08
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 17 Nov 2025
- Transactions
- 1
- Transaction value
- +$7,000
- Accepted by SEC
- 17 Nov 2025, 13:12
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 14 Oct 2025
- Transactions
- 2
- Transaction value
- +$57,200
- Accepted by SEC
- 15 Oct 2025, 16:05
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 12 Sep 2025
- Transactions
- 1
- Transaction value
- +$9,885
- Accepted by SEC
- 15 Sep 2025, 09:00
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 05 Aug 2025
- Transactions
- 1
- Transaction value
- +$50,000
- Accepted by SEC
- 06 Aug 2025, 09:00
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 24 Jul 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 25 Jul 2025, 16:01
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 12 Jun 2025
- Transactions
- 1
- Transaction value
- +$7,372
- Accepted by SEC
- 16 Jun 2025, 08:27
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 19 May 2025
- Transactions
- 1
- Transaction value
- +$8,730
- Accepted by SEC
- 19 May 2025, 12:43
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 26 Mar 2025
- Transactions
- 1
- Transaction value
- +$100,000
- Accepted by SEC
- 27 Mar 2025, 08:13
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 29 Jan 2025
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 31 Jan 2025, 16:05
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 09 Dec 2024
- Transactions
- 1
- Transaction value
- +$80,000
- Accepted by SEC
- 10 Dec 2024, 16:01
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 01 Sep 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 04 Sep 2024, 16:03
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 15 Aug 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 16 Aug 2024, 16:05
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 01 Jun 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 04 Jun 2024, 16:06
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 24 Jan 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 26 Jan 2024, 16:01
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 08 Dec 2023
- Transactions
- 1
- Transaction value
- +$6,700
- Accepted by SEC
- 11 Dec 2023, 08:51
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 19 Oct 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 20 Oct 2023, 16:02
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 16 Aug 2023
- Transactions
- 1
- Transaction value
- +$12,200
- Accepted by SEC
- 16 Aug 2023, 12:28
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 05 Jul 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 07 Jul 2023, 16:02
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 12 Jan 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 13 Jan 2023, 15:01
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 13 Oct 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 14 Oct 2022, 16:08
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 04 Oct 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 06 Oct 2022, 16:05
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 30 Aug 2022
- Transactions
- 1
- Transaction value
- +$5,635
- Accepted by SEC
- 30 Aug 2022, 11:19
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 23 Jun 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 24 Jun 2022, 16:04
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 07 Apr 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 08 Apr 2022, 16:05
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 08 Dec 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 10 Dec 2021, 15:05
- Role
- President and CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 03 Nov 2021
- Transactions
- 6
- Transaction value
- $0
- Accepted by SEC
- 05 Nov 2021, 16:06
- Role
- President & CEO, Director
- Next action
- Open filing details
4
VNRX
VOLITIONRX LTD
- Report period
- 14 Jul 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 16 Jul 2021, 16:38
- Role
- President and CEO, Director
- Next action
- Open filing details